Sanofi
Sanofi claims $109m impact on revenue following recall
November 3, 2015Manufacturing and Production Sanofi, finance, maufacturing, product recall
As Sanofi recalls its Auvi-Q epinephrine injection for the treatment of severe allergic reactions – after the company found the …
Sanofi and BioNTech in cancer immunotherapy partnership
November 3, 2015Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy
Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …
Sanofi recalls allergy injection pens
October 29, 2015Manufacturing and Production Allerject, Sanofi, anaphylaxis
Sanofi has halted manufacturing and is recalling its Allerject auto-injectors following a blunder involving incorrect dosages. The voluntary recall involves …
Sanofi and Regeneron heart drug Praluent available in UK
October 19, 2015Sales and Marketing Regeneron, Sanofi, alicrocumab, high cholesterol, praluent
Sanofi and Regeneron’s next-generation cholesterol-lowering treatment Praluent is now available for adult patients with high cholesterol in the UK, following …
Sanofi looks to increase productivity in France by 25%
October 9, 2015Manufacturing and Production, Medical Communications Sanofi
Sanofi is looking for a deal with unions in order to boost productivity by 20-25% at French plants over three …
Sanofi MS treatment Aubagio slows brain atrophy in Phase III trial
October 7, 2015Research and Development Genzyme, MS, Sanofi
Sanofi and its subsidiary Genzyme have announced that magnetic resonance imaging (MRI) data from the Phase III TEMSO study demonstrate …
Genzyme opts into Alnylam’s Thrombosis program
October 2, 2015Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia
Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
Sanofi and Regeneron given European nod for Praluent
September 28, 2015Sales and Marketing European Commission, Regeneron, Sanofi, alirocumab, high cholesterol, marketing authorisation, praluent
The European Commission (EC) has approved the marketing authorisation of Sanofi and Regeneron’s cholesterol drug Praluent. The heart drug is …
Brandicourt set to continue Sanofi restructure
September 28, 2015Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off
Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …
Sanofi’s LixiLan meets target in Phase III diabetes trial
September 16, 2015Research and Development Lantus, LixiLan, Lixisenatide, Lxyumia, Sanofi, diabetes, insulin glargine, metformin, type 2 diabetes
Sanofi’s Phase III clinical trial of its Lixilan treatment has achieved its primary endpoint in patients with type 2 diabetes, …
Sanofi to significantly expand UK inhaler plant
September 15, 2015Manufacturing and Production Cheshire, Sanofi, manufacturing, production
Sanofi is gearing up for significant expansion of its inhaler production complex in Cheshire, England. The French pharma giant has …
Sanofi joins Google in diabetes tech push
September 1, 2015Medical Communications Andy Conrad, Google life sciences, Sanofi, Type 1 diabetes, diabetes, google, type 2 diabetes
Google is continuing its work in diabetes, by teaming up with pharma giants Sanofi to create new digital technologies and …
Sanofi, Evotec and Apeiron partner on immuno-oncology
August 10, 2015Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours
Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
Sanofi launches new insulin Toujeo in the UK
August 4, 2015Manufacturing and Production, Sales and Marketing Lantus, Sanofi, biosimilars, diabetes, hypoglycaemia, insulin, toujeo
Sanofi’s new insulin Toujeo is now available for clinicians to prescribe in the UK. The French firm is looking to …
Sanofi sales boosted by rare disease and multiple sclerosis drugs
July 30, 2015Manufacturing and Production, Sales and Marketing Genzyme, Oliver Brandicourt, Sanofi, brandicourt, financial results
Sales at pharma giant Sanofi increased by 5% in the second quarter of 2016 to nearly €10 billion, its latest …
Latest content
Five Facts about cardiovascular disease
